These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6847037)

  • 1. In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents.
    Casal MJ; Rodriguez FC
    Ann Microbiol (Paris); 1983; 134A(1):73-8. PubMed ID: 6847037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.
    Stone MS; Wallace RJ; Swenson JM; Thornsberry C; Christensen LA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):486-93. PubMed ID: 6651277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility to antibiotics and sulfonamides of atypical mycobacteria isolated in South America.
    de Kantor IN; Barrera L; di Lonardo M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):247-53. PubMed ID: 4082825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M; Rodriguez F
    Ann Microbiol (Paris); 1981; 132B(1):51-6. PubMed ID: 7305191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM; Wallace RJ; Silcox VA; Thornsberry C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ; Rodriguez FC; Benavente MC
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
    Wallace RJ; Dalovisio JR; Pankey GA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):611-4. PubMed ID: 526002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents.
    Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
    J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.
    Cynamon MH; Patapow A
    Antimicrob Agents Chemother; 1981 Jan; 19(1):205-7. PubMed ID: 7247358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.
    Collins CH; Yates MD; Uttley AH
    J Hyg (Lond); 1985 Dec; 95(3):619-21. PubMed ID: 2936800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of Mycobacterium fortuitum biovariant fortuitum and the unnamed third biovariant complex to heavy-metal salts.
    Wallace RJ; Steele LC; Forrester GD; Swenson JM; Hull SI
    Antimicrob Agents Chemother; 1984 Oct; 26(4):594-6. PubMed ID: 6517549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.
    Swenson JM; Thornsberry C; Silcox VA
    Antimicrob Agents Chemother; 1982 Aug; 22(2):186-92. PubMed ID: 6927280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates.
    Koontz FP; Erwin ME; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):183-6. PubMed ID: 7821001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A drug sensitivity test strategy for atypical mycobacteria.
    Hejný J
    Tubercle; 1982 Mar; 63(1):63-9. PubMed ID: 7082424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1983 Jun; 23(6):935-7. PubMed ID: 6604496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.